Dr. Reddy's Laboratories (RDY) News Today $12.70 +0.01 (+0.04%) Closing price 03:59 PM EasternExtended Trading$12.74 +0.04 (+0.28%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Purchased by Assetmark Inc.Assetmark Inc. lifted its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 443.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 204,715 shares of the company's stock after acquiring an addMarch 10 at 3:55 AM | marketbeat.comWest Family Investments Inc. Boosts Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)West Family Investments Inc. increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 481.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 76,936 shares of the compMarch 8 at 6:34 AM | marketbeat.comSchechter Investment Advisors LLC Has $446,000 Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)Schechter Investment Advisors LLC increased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 383.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 28,247 shares of the company's stock after purchasing an additional 22,401 sharMarch 6, 2025 | marketbeat.comUS Bancorp DE Has $3.61 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)US Bancorp DE boosted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 552.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 228,301 shares of the company's stock after purchasing an additional 193,288March 6, 2025 | marketbeat.comDr. Reddy's Laboratories advances Tuesday, outperforms marketMarch 6, 2025 | marketwatch.comQRG Capital Management Inc. Boosts Stake in Dr. Reddy's Laboratories Limited (NYSE:RDY)QRG Capital Management Inc. raised its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 379.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,283 shares of the compMarch 5, 2025 | marketbeat.comFisher Asset Management LLC Has $38.98 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Fisher Asset Management LLC grew its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 402.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,468,722 shares of the company's stock after purchasing an adMarch 3, 2025 | marketbeat.comIs Dr. Reddy’s Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts?March 1, 2025 | uk.finance.yahoo.comDr. Reddy's Laboratories slides Friday, still outperforms marketFebruary 28, 2025 | marketwatch.comRhumbline Advisers Raises Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Rhumbline Advisers raised its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 458.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 430,062 shares ofFebruary 26, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Sets New 12-Month Low - Here's WhyDr. Reddy's Laboratories (NYSE:RDY) Reaches New 12-Month Low - Time to Sell?February 25, 2025 | marketbeat.comDr. Reddy's Laboratories slips Tuesday, underperforms competitorsFebruary 25, 2025 | marketwatch.comDr. Reddy's Laboratories rallies Monday, outperforms competitorsFebruary 24, 2025 | marketwatch.comDr. Reddy's Laboratories (NYSE:RDY) Hits New 1-Year Low - Here's What HappenedDr. Reddy's Laboratories (NYSE:RDY) Hits New 52-Week Low - Should You Sell?February 20, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Stock Holdings Lifted by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC grew its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 534,304 shares of the compaFebruary 19, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Stock Holdings Increased by Blue Trust Inc.Blue Trust Inc. boosted its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 165.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,085 shares of the company's stock after buyingFebruary 18, 2025 | marketbeat.comZacks Research Issues Pessimistic Estimate for RDY EarningsDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Stock analysts at Zacks Research lowered their FY2026 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a report issued on Wednesday, February 12th. Zacks Research analyst R. Department now forecasts that the company wilFebruary 15, 2025 | marketbeat.comV Square Quantitative Management LLC Increases Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)V Square Quantitative Management LLC boosted its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 568.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investoFebruary 15, 2025 | marketbeat.comLester Murray Antman dba SimplyRich Increases Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Lester Murray Antman dba SimplyRich boosted its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 465.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 37,423 shares of the company's stock after acquiring an additional 30,806 sharFebruary 12, 2025 | marketbeat.comAugustine Asset Management Inc. Boosts Stock Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Augustine Asset Management Inc. raised its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 392.6% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 249,744 shares of the company's stock after acquiringFebruary 12, 2025 | marketbeat.comXY Capital Ltd Invests $1.06 Million in Dr. Reddy's Laboratories Limited (NYSE:RDY)XY Capital Ltd acquired a new position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 67,209 shares of the company's stock, valued at approximaFebruary 10, 2025 | marketbeat.comZacks Research Has Bearish Estimate for RDY Q1 EarningsDr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a research report issued on Thursday, February 6th. Zacks Research analyst R. Department now anticipates that the compaFebruary 10, 2025 | marketbeat.comMigdal Insurance & Financial Holdings Ltd. Raises Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Migdal Insurance & Financial Holdings Ltd. lifted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 217.5% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 100,000 shares of the companyFebruary 7, 2025 | marketbeat.comDr. Reddy's enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and EuropeFebruary 6, 2025 | businesswire.comHenlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.February 6, 2025 | prnewswire.comE. Ohman J or Asset Management AB Purchases 38,400 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)E. Ohman J or Asset Management AB raised its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 48,000 shares of the company's stockFebruary 6, 2025 | marketbeat.comCaprock Group LLC Acquires 43,165 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Caprock Group LLC boosted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 280.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 58,563 shares of the company's stoFebruary 4, 2025 | marketbeat.comGreenleaf Trust Has $1.86 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Greenleaf Trust lifted its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 117,611 shares of the company'sFebruary 3, 2025 | marketbeat.comDr. Reddy's Lab: Near-Term Worries And Underappreciated Potential Could Lead To Huge ReturnsJanuary 30, 2025 | seekingalpha.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Hanson & Doremus Investment ManagementHanson & Doremus Investment Management grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,170 shares of the company's stock after purchasing an additional 18January 30, 2025 | marketbeat.comSmith Group Asset Management LLC Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Smith Group Asset Management LLC purchased a new position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 43,400 shaJanuary 29, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Robeco Institutional Asset Management B.V.Robeco Institutional Asset Management B.V. lifted its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 453.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,438,908 shares of the company'sJanuary 29, 2025 | marketbeat.comDr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2025 Earnings Call TranscriptJanuary 28, 2025 | msn.comDr. Reddy's Laboratories (NYSE:RDY) Sets New 52-Week Low - Time to Sell?Dr. Reddy's Laboratories (NYSE:RDY) Sets New 12-Month Low - Should You Sell?January 27, 2025 | marketbeat.comDGS Capital Management LLC Increases Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)DGS Capital Management LLC boosted its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 528.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,993 shares of the company's stockJanuary 25, 2025 | marketbeat.comIndian drugmaker Dr Reddy's shares slide after Q3 profit missJanuary 24, 2025 | msn.comDr. Reddy's Laboratories Limited 2025 Q3 - Results - Earnings Call PresentationJanuary 24, 2025 | seekingalpha.comLifestyle Asset Management Inc. Buys 57,799 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Lifestyle Asset Management Inc. raised its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 422.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 71,488 shares of the company's stock after purchasing an additionJanuary 24, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (RDY) Q3 2025 Earnings Call TranscriptJanuary 23, 2025 | seekingalpha.comDr. Reddy's Laboratories (NYSE:RDY) Stock Price Down 5.5% - Here's WhyDr. Reddy's Laboratories (NYSE:RDY) Shares Down 5.5% - Here's What HappenedJanuary 23, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Announces Quarterly Earnings ResultsDr. Reddy's Laboratories (NYSE:RDY - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.01. Dr. Reddy's Laboratories had a net margin of 17.81% and a return on equity of 18.53%.January 23, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Issues Quarterly Earnings ResultsDr. Reddy's Laboratories (NYSE:RDY - Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.01. Dr. Reddy's Laboratories had a net margin of 17.81% and a return on equity of 18.53%.January 23, 2025 | marketbeat.comDr. Reddy's Q3 & 9MFY25 Financial ResultsJanuary 23, 2025 | businesswire.comCLSA lowers Dr. Reddy's shares price target, citing lack of near-term growth triggersJanuary 23, 2025 | msn.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Ballentine Partners LLCBallentine Partners LLC increased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 577.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 104,715 shares of the company's stock afterJanuary 22, 2025 | marketbeat.comDr. Reddy's Laboratories (RDY) Expected to Announce Quarterly Earnings on WednesdayDr. Reddy's Laboratories (NYSE:RDY) will be releasing earnings on Wednesday, January 29, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=656418)January 22, 2025 | marketbeat.comBridgewater Advisors Inc. Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Bridgewater Advisors Inc. purchased a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 31,093 shares of the company's stock, valued at approximateJanuary 20, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Artemis Investment Management LLPArtemis Investment Management LLP lifted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 398.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 295,530 shares of the company's stockJanuary 20, 2025 | marketbeat.comRitholtz Wealth Management Has $1.27 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Ritholtz Wealth Management raised its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 362.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 80,595 shares of the company's stock after purchasing an additionalJanuary 19, 2025 | marketbeat.comDr. Reddy’s Laboratories Ltd ADRJanuary 16, 2025 | 247wallst.com Remove Ads Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address RDY Media Mentions By Week RDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼1.230.60▲Average Medical News Sentiment RDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼63▲RDY Articles Average Week Remove Ads Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies argenx News BioNTech News Beigene News Teva Pharmaceutical Industries News Genmab A/S News Intra-Cellular Therapies News Moderna News Summit Therapeutics News Viatris News Sarepta Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RDY Stock Alerts